Rankings
▼
Calendar
SMMT Q1 2024 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$27,000
Operating Income
-$42M
Net Income
-$43M
EPS (Diluted)
$-0.06
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$30M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$177M
Total Liabilities
$133M
Stockholders' Equity
$44M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$27,000
$0
—
Operating Income
-$42M
-$537M
+92.1%
Net Income
-$43M
-$542M
+92.0%
← FY 2024
All Quarters
Q2 2024 →